Journal article icon

Journal article

Informing optimal testing and isolation strategies across different stages of the diagnostic development pipeline using mathematical models: SARS-CoV-2 in the UK as a case study

Abstract:
IntroductionMass testing strategies recognise the importance of rapidly identifying individuals infected with potentially asymptomatic pathogens to mitigate outbreaks. A pressing question is how to design testing strategies that navigate the delicate balance between reducing morbidity and minimising societal disruption and absenteeism among key workers while balancing associated logistical and financial considerations.MethodsWe use an individual-based model with explicit viral dynamics to explore the inherent trade-offs in testing regimen design and identify optimal regimens for different stages of a pandemic. Applying this framework to the SARS-CoV-2 pandemic in the UK, we evaluate the impact of testing and isolation protocols on two key objectives: protecting the vulnerable and reducing transmission. Each testing regimen is evaluated according to three outcomes: reduction in infectivity, testing efficiency and isolation efficiency.ResultsOur analysis shows that these outcomes are on orthogonal optimisation axes, indicating a sharp trade-off between strategic goals. This implies that transmission reduction strategies are inherently inefficient and that regimens with high testing efficiency will always have suboptimal isolation efficiency. By focusing on testing regimens to protect vulnerable groups, we map the predicted outcomes across different stages of the diagnostic development pipeline. We also examine how adherence to testing and isolation guidelines may influence the selection of regimens aimed at reducing overall transmission.ConclusionsBased on these findings, we offer a framework to streamline the selection process for robust testing strategies spanning the duration of a pandemic, ensuring consistently high levels of adherence and thus impact.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/bmjph-2025-002993

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-6507-6597
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-7405-7507


Publisher:
BMJ Publishing Group
Journal:
BMJ Public Health More from this journal
Volume:
4
Issue:
2
Pages:
e002993
Publication date:
2026-05-14
Acceptance date:
2026-03-31
DOI:
EISSN:
2753-4294
ISSN:
2753-4294
Pmid:
42205610


Language:
English
Keywords:
Source identifiers:
4118764
Deposit date:
2026-06-05
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP